Simon Thomas

1.6k total citations
28 papers, 773 citations indexed

About

Simon Thomas is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Simon Thomas has authored 28 papers receiving a total of 773 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Oncology, 10 papers in Immunology and 9 papers in Molecular Biology. Recurrent topics in Simon Thomas's work include CAR-T cell therapy research (25 papers), Virus-based gene therapy research (6 papers) and Viral Infectious Diseases and Gene Expression in Insects (5 papers). Simon Thomas is often cited by papers focused on CAR-T cell therapy research (25 papers), Virus-based gene therapy research (6 papers) and Viral Infectious Diseases and Gene Expression in Insects (5 papers). Simon Thomas collaborates with scholars based in United Kingdom, United States and Italy. Simon Thomas's co-authors include Martin Pulé, Brian Philip, Karin Straathof, Evangelia Kokalaki, Barry Flutter, Ronjon Chakraverty, Karl S. Peggs, Leila Mekkaoui, Virna Marin and Teresa Marafioti and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Simon Thomas

27 papers receiving 749 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Simon Thomas United Kingdom	10	677	279	266	215	201	28	773
Reona Sakemura United States	13	717 1.1×	249 0.9×	261 1.0×	227 1.1×	261 1.3×	54	879
Stefanie Lesch Germany	8	686 1.0×	284 1.0×	211 0.8×	188 0.9×	278 1.4×	10	798
ChingLam W. Wong United States	7	944 1.4×	359 1.3×	312 1.2×	323 1.5×	381 1.9×	8	1.0k
Eugenia Zah United States	4	659 1.0×	231 0.8×	269 1.0×	176 0.8×	211 1.0×	5	700
Brenna Hansen United States	6	785 1.2×	350 1.3×	249 0.9×	193 0.9×	250 1.2×	7	889
Ryan Urak United States	15	910 1.3×	425 1.5×	301 1.1×	254 1.2×	402 2.0×	31	1.1k
Annalisa Cabriolu United States	6	787 1.2×	351 1.3×	323 1.2×	223 1.0×	323 1.6×	9	974
Sanfang Tu China	16	582 0.9×	297 1.1×	144 0.5×	154 0.7×	201 1.0×	52	858
Julian Rydzek Germany	5	741 1.1×	300 1.1×	265 1.0×	205 1.0×	287 1.4×	7	850
Diogo Gomes‐Silva United States	6	759 1.1×	329 1.2×	180 0.7×	312 1.5×	274 1.4×	9	857

Countries citing papers authored by Simon Thomas

Since Specialization

Citations

This map shows the geographic impact of Simon Thomas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simon Thomas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simon Thomas more than expected).

Fields of papers citing papers by Simon Thomas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Simon Thomas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simon Thomas. The network helps show where Simon Thomas may publish in the future.

Co-authorship network of co-authors of Simon Thomas

This figure shows the co-authorship network connecting the top 25 collaborators of Simon Thomas. A scholar is included among the top collaborators of Simon Thomas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Simon Thomas. Simon Thomas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hotblack, Alastair, Reyisa Bughda, Anna Bulek, et al.. (2024). Designer Small-Molecule Control System Based on Minocycline-Induced Disruption of Protein–Protein Interaction. ACS Chemical Biology. 19(2). 308–324. 4 indexed citations

Robson, Mathew, Evangelia Kokalaki, Francesco Nannini, et al.. (2023). Enhancing CAR T-cell Therapy Using Fab-Based Constitutively Heterodimeric Cytokine Receptors. Cancer Immunology Research. 11(9). 1203–1221. 6 indexed citations

Robson, Mathew, Christopher Allen, James Sillibourne, et al.. (2023). Novel Fas-TNFR chimeras that prevent Fas ligand-mediated kill and signal synergistically to enhance CAR T cell efficacy. Molecular Therapy — Nucleic Acids. 32. 603–621. 4 indexed citations

Bulek, Anna, Mathew Robson, Evangelia Kokalaki, et al.. (2023). Exploration of T cell immune responses by expression of a dominant-negative SHP1 and SHP2. Frontiers in Immunology. 14. 1119350–1119350. 3 indexed citations

Hotblack, Alastair, Evangelia Kokalaki, Gordon Weng-Kit Cheung, et al.. (2021). Tunable control of CAR T cell activity through tetracycline mediated disruption of protein–protein interaction. Scientific Reports. 11(1). 21902–21902. 18 indexed citations

Peruta, Marco Della, Mathew Robson, Philip Fei Wu, et al.. (2020). Abstract 1070: AUTO7: Anti-PSMA humanized CAR T-cell with improved persistence and resistance to tumor microenvironment for metastatic castration resistant prostate cancer (mCRPC). Cancer Research. 80(16_Supplement). 1070–1070. 1 indexed citations

Tholouli, Eleni, Wendy Osborne, Carlos Bachier, et al.. (2020). 890MO Phase I Alexander study of AUTO3, the first CD19/22 dual targeting CAR.T cell, with pembrolizumab in patients with relapsed/refractory (r/r) DLBCL. Annals of Oncology. 31. S651–S651. 4 indexed citations

Popat, Rakesh, Sonja Zweegman, Jim Cavet, et al.. (2019). Phase 1 First-in-Human Study of AUTO2, the First Chimeric Antigen Receptor (CAR) T Cell Targeting APRIL for Patients with Relapsed/Refractory Multiple Myeloma (RRMM). Blood. 134(Supplement_1). 3112–3112. 45 indexed citations

Philip, Brian, Christopher G. Davis, Shimobi Onuoha, et al.. (2018). A Rapamycin-Activated Caspase 9-Based Suicide Gene. Molecular Therapy. 26(5). 1266–1276. 72 indexed citations

10.

Ardeshna, Kirit M., Maria A. V. Marzolini, Wendy Osborne, et al.. (2018). Study of AUTO3, the First Bicistronic Chimeric Antigen Receptor (CAR) Targeting CD19 and CD22, Followed By Anti-PD1 Consolidation in Patients with Relapsed/Refractory (r/r) Diffuse Large B Cell Lymphoma (DLBCL): Alexander Study. Blood. 132(Supplement 1). 1679–1679. 8 indexed citations

11.

Baldan, Vania, Evangelia Kokalaki, Shimobi Onuoha, et al.. (2017). A Dominant Negative SHP-2 Which Abrogates PD-1 Signalling Pathways and Restores Function of Cytotoxic CAR T Cells. Blood. 130. 3190–3190. 5 indexed citations

12.

Thomas, Simon, Vania Baldan, Evangelia Kokalaki, et al.. (2017). A DUAL TARGETING CAR‐T CELL APPROACH FOR THE TREATMENT OF B CELL MALIGNANCIES. Hematological Oncology. 35(S2). 261–261. 1 indexed citations

13.

Lee, Lydia, Benjamin Draper, Brian Philip, et al.. (2017). An APRIL-based chimeric antigen receptor for dual targeting of BCMA and TACI in multiple myeloma. Blood. 131(7). 746–758. 134 indexed citations

14.

Thomas, Simon, Karin Straathof, Nourredine Himoudi, John Anderson, & Martin Pulé. (2016). An Optimized GD2-Targeting Retroviral Cassette for More Potent and Safer Cellular Therapy of Neuroblastoma and Other Cancers. PLoS ONE. 11(3). e0152196–e0152196. 48 indexed citations

15.

Draper, Benjamin, Brian Philip, Simon Thomas, et al.. (2016). An APRIL Based Chimeric Antigen Receptor to Simultaneously Target BCMA and TACI in Multiple Myeloma (MM) Has Potent Activity in Vitro and in Vivo. Blood. 128(22). 379–379. 2 indexed citations

16.

Willoughby, Jamin A., et al.. (2015). Evaluation of an In Vitro Human Dermal Sensitization Test for Use with Medical Device Extracts. 1(2). 118–130. 16 indexed citations

17.

Philip, Brian, Evangelia Kokalaki, Leila Mekkaoui, et al.. (2014). A highly compact epitope-based marker/suicide gene for easier and safer T-cell therapy. Blood. 124(8). 1277–1287. 303 indexed citations

18.

Peggs, Karl S., Eleni Tholouli, Ronjon Chakraverty, et al.. (2014). CMV~IMPACT: Results of a Randomized Controlled Trial of Immuno-Prophylactic Adoptive Cellular Therapy following Sibling Donor Allogeneic HSCT. Blood. 124(21). 1109–1109. 7 indexed citations

19.

Chen, Frederick, Andrew Peniket, Eleni Tholouli, et al.. (2014). CMV-Specific T-Cell Therapy Improves Immune Reconstitution Following Unrelated Donor HSCT: Results of a Randomized Controlled Trial. Biology of Blood and Marrow Transplantation. 20(2). S49–S49. 3 indexed citations

20.

Fisher, Andrew, Simon Thomas, Caroline Joyce, Peter Strike, & I. Karen Temple. (2001). A patient with growth retardation and a duplication of the Beckwith Wiedemann critical region of maternal origin. ePrints Soton (University of Southampton). 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact